Navigation Links
CDC Reports Drop in Adult Smoking, But Death Toll and Health Costs Are Still Growing; Congress, States Should Implement Proven Solutions
Date:11/13/2008

roducts; require tobacco

companies to disclose the contents of tobacco products; grant the FDA

authority to regulate the contents of tobacco products; and stop tobacco

companies from making misleading or unproven health claims.

-- Congress should also significantly increase the federal tobacco tax and

utilize some of the revenue to fund a national public education and

smoking cessation campaign. The report's finding that fewer adults

are trying to quit smoking makes critical that we undertake efforts to

encourage them to do so and help them succeed.

-- The states must redouble efforts to increase tobacco taxes, enact

comprehensive smoke-free workplace laws and fund tobacco prevention and

cessation programs at CDC-recommended levels. Most states have failed to

fund these programs at recommended levels and spend only about three

percent of the billions of dollars they collect each year from the

tobacco settlement and tobacco taxes on tobacco prevention and

cessation. The states are spending $718.1 million this year on tobacco

prevention programs, which is 269 times less than the health care and

productivity costs of smoking.

Reductions in adult smoking have been largely the result of efforts at the state and local level, including higher tobacco taxes, a growing number of smoke-free laws and well-funded tobacco prevention and cessation programs in some states. The few states and localities that have implemented a comprehensive strategy that includes all three measures have been especially successful. For example, Washington state and New York City have reduced adult smoking rates to 16.5 percent and 16.9 percent respectively, well below the national rate.

While continued state and local efforts are critical, the IOM report concluded that the states alone cannot solve the tobacco problem. The fe
'/>"/>

SOURCE Campaign for Tobacco-Free Kids
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Nile Therapeutics, Inc. Reports 2008 Third Quarter Financial Results
2. Misonix Reports First Quarter Fiscal Year 2009 Financial Results
3. Corgenix Reports Financial Results for First Quarter of Fiscal 2009
4. MiddleBrook Pharmaceuticals Reports Third Quarter 2008 Financial Results
5. Spheris Reports Third Quarter 2008 Results
6. MAP Pharmaceuticals Reports Third Quarter of 2008 Financial Results
7. Symmetry Medical Reports Third Quarter 2008 Financial Results
8. EntreMed Reports Clinical Program Progress and Company Update
9. NBTY Reports Fourth Quarter and Fiscal Year Results
10. IPC The Hospitalist Company Reports Record Third Quarter 2008 Results
11. Consumer Reports Survey: Nearly Half of Adults Wont Get Flu Vaccine, Citing Poor Excuses Like I Dont Get Sick
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:GSK Study Showed Targeted Therapy Combination Achieved 14 Month Overall Survival in Patients with Advanced Breast Cancer 2GSK Study Showed Targeted Therapy Combination Achieved 14 Month Overall Survival in Patients with Advanced Breast Cancer 3GSK Study Showed Targeted Therapy Combination Achieved 14 Month Overall Survival in Patients with Advanced Breast Cancer 4GSK Study Showed Targeted Therapy Combination Achieved 14 Month Overall Survival in Patients with Advanced Breast Cancer 5GSK Study Showed Targeted Therapy Combination Achieved 14 Month Overall Survival in Patients with Advanced Breast Cancer 6Pro-Dex, Inc. Announces Results of Annual Shareholder Meeting, an Update Regarding Major Customer's Product Development Plans, and Receipt of $1.5 Million and $3.0 Million Purchase Orders 2Pro-Dex, Inc. Announces Results of Annual Shareholder Meeting, an Update Regarding Major Customer's Product Development Plans, and Receipt of $1.5 Million and $3.0 Million Purchase Orders 3Pro-Dex, Inc. Announces Results of Annual Shareholder Meeting, an Update Regarding Major Customer's Product Development Plans, and Receipt of $1.5 Million and $3.0 Million Purchase Orders 4New Executive Leadership and CEO Announced for BiPar Sciences 2Study on keeping nuclear bombs from US ports shows misplaced fear over cargo scanning cost 12946 1Study on keeping nuclear bombs from US ports shows misplaced fear over cargo scanning cost 12946 2Study on keeping nuclear bombs from US ports shows misplaced fear over cargo scanning cost 12946 3Study on keeping nuclear bombs from US ports shows misplaced fear over cargo scanning cost 12946 4Research shows that invisible hand guides evolution of cooperative turn taking 9182 1Research shows that invisible hand guides evolution of cooperative turn taking 9182 2Rigel to Host Conference Call to Discuss Results of Its Phase 2b TASKi2 Clinical Trial of R788 in Rheumatoid Arthritis 4702 1Rigel to Host Conference Call to Discuss Results of Its Phase 2b TASKi2 Clinical Trial of R788 in Rheumatoid Arthritis 4702 2